Expert NetworkExpert InterviewAZN

Slingshot members are talking to an expert! The topic is:

Discussing the potential of AstraZeneca and Ionis’ eplontersen in patients with hereditary transthyretin-mediated amyloid polyneuropathy with a neurologist.

Executed on:May 31, 2023 4:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Utah Hospital and Clinics
  • Assistant Professor of Neuromuscular Medicine at the University of Utah and Neurologic specialist in the Regional Amyloidosis Program at the Huntsman Cancer Institute.
  • Manages ~12 patients with ATTRv-PN.
  • Academic interests include cancer and chemotherapy related neuromuscular complications and amyloidosis.

Interview Goal

On this call we will be discussing the Phase III NEURO-TTRansform results presented at 2023 AAN Annual Meeting for eplontersen in patients with ATTRv-PN.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.